Taniguchi K, Itakura K, Yamazawa N, Morisaki K, Hayashi S, Yamada Y
Research and Development Division, Rohto Pharmaceutical Co., Ltd., Osaka, Japan.
J Pharmacobiodyn. 1988 Jan;11(1):39-46. doi: 10.1248/bpb1978.11.39.
The efficacy of a liposome preparation on ocular steroid availability was investigated by both tracer studies and investigation of in vivo steroid uptake by the cornea. Dexamethasone and its ester derivatives were used as model drugs and aqueous suspensions of each served as control preparations. The liposome preparation containing dexamethasone valerate provided the highest ocular drug levels among the examined preparations. In the case of dexamethasone or dexamethasone palmitate, the liposomal form provided a lower drug level in comparison with the suspension. High esterase activity for dexamethasone valerate was observed in the corneal homogenate supernatant, and most of the steroid taken up after instillation of dexamethasone valerate was metabolized to free alcohol. The corneal dexamethasone level was almost proportional to the concentration of free dexamethasone valerate in the liposome preparation. Only the addition of stearylamine (SA) to the liposomal membrane had an added extra effect on the corneal absorption of dexamethasone valerate.
通过示踪研究以及对角膜体内类固醇摄取的研究,对脂质体制剂对眼部类固醇可用性的功效进行了调查。地塞米松及其酯衍生物用作模型药物,每种药物的水悬浮液用作对照制剂。在所检查的制剂中,含有戊酸地塞米松的脂质体制剂提供了最高的眼部药物水平。在地塞米松或棕榈酸地塞米松的情况下,脂质体形式与悬浮液相比提供了较低的药物水平。在角膜匀浆上清液中观察到戊酸地塞米松具有高酯酶活性,并且滴注戊酸地塞米松后摄取的大部分类固醇被代谢为游离醇。角膜地塞米松水平几乎与脂质体制剂中游离戊酸地塞米松的浓度成正比。仅在脂质体膜中添加硬脂胺(SA)对戊酸地塞米松的角膜吸收有额外的附加作用。